BIODESIX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
BIODESIX, INC. (BDSX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 307.00 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-05
- BIODESIX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 6.00K shares, a 98.66% decline year-over-year.
- BIODESIX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 301.00K shares, a 87.64% decline year-over-year.
- BIODESIX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 9.00K shares, a 95.16% decline year-over-year.
- BIODESIX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was -2.74M shares, a 3209.09% decline year-over-year.
- BIODESIX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 157.00K shares, a 93.49% decline from fiscal 2024.
- BIODESIX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 2.41M shares, a 431.28% increase from fiscal 2023.
- BIODESIX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 454.00K shares, a 19.47% increase from fiscal 2022.
- BIODESIX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 380.00K shares, a 31832.77% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 6.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | 307.00K shares 10-Q · filed 2026-08-05 | 316.00K shares derived: sum of 3 quarters · filed 2026-08-05 | -2.42M shares derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 301.00K shares 10-Q · filed 2026-05-04 | 310.00K shares derived: sum of 2 quarters · filed 2026-05-04 | -2.43M shares derived: sum of 3 quarters · filed 2026-05-04 | -1.98M shares derived: sum of 4 quarters · filed 2026-05-04 |
| 2025-12-31 | 9.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -2.73M shares derived: sum of 2 quarters · filed 2026-02-26 | -2.28M shares derived: sum of 3 quarters · filed 2026-02-26 | 157.00K shares 10-K · filed 2026-02-26 |
| 2025-09-30 | -2.74M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -2.29M shares derived: sum of 2 quarters · filed 2025-11-03 | 148.00K shares 10-Q · filed 2025-11-03 | 334.00K shares derived: sum of 4 quarters · filed 2025-11-03 |
| 2025-06-30 | 448.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 2.88M shares 10-Q · filed 2025-08-07 | 3.07M shares derived: sum of 3 quarters · filed 2025-08-07 | 3.16M shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | 2.44M shares 10-Q · filed 2025-05-13 | 2.62M shares derived: sum of 2 quarters · filed 2025-05-13 | 2.71M shares derived: sum of 3 quarters · filed 2025-05-13 | 3.15M shares derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | 186.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 274.00K shares derived: sum of 2 quarters · filed 2025-03-03 | 714.00K shares derived: sum of 3 quarters · filed 2025-03-03 | 2.41M shares 10-K · filed 2025-03-03 |
| 2024-09-30 | 88.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | 528.00K shares derived: sum of 2 quarters · filed 2024-11-01 | 2.23M shares 10-Q · filed 2024-11-01 | 2.25M shares derived: sum of 4 quarters · filed 2024-11-01 |
| 2024-06-30 | 440.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | 2.14M shares 10-Q · filed 2024-08-07 | 2.17M shares derived: sum of 3 quarters · filed 2024-08-07 | 2.22M shares derived: sum of 4 quarters · filed 2024-08-07 |
| 2024-03-31 | 1.70M shares 10-Q · filed 2024-05-08 | 1.73M shares derived: sum of 2 quarters · filed 2024-05-08 | 1.78M shares derived: sum of 3 quarters · filed 2024-05-08 | 1.81M shares derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | 27.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | 82.00K shares derived: sum of 2 quarters · filed 2024-03-01 | 110.00K shares derived: sum of 3 quarters · filed 2024-03-01 | 454.00K shares 10-K · filed 2024-03-01 |
| 2023-09-30 | 55.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 83.00K shares derived: sum of 2 quarters · filed 2023-11-07 | 427.00K shares 10-Q · filed 2023-11-07 | 478.00K shares derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | 28.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | 372.00K shares 10-Q · filed 2023-08-07 | 423.00K shares derived: sum of 3 quarters · filed 2023-08-07 | 475.00K shares derived: sum of 4 quarters · filed 2023-08-07 |
| 2023-03-31 | 344.00K shares 10-Q · filed 2023-05-11 | 395.00K shares derived: sum of 2 quarters · filed 2023-05-11 | 447.00K shares derived: sum of 3 quarters · filed 2023-05-11 | 489.00K shares derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | 51.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | 103.00K shares derived: sum of 2 quarters · filed 2023-03-06 | 145.00K shares derived: sum of 3 quarters · filed 2023-03-06 | 380.00K shares 10-K · filed 2023-03-06 |
| 2022-09-30 | 52.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 94.00K shares derived: sum of 2 quarters · filed 2022-11-03 | 329.00K shares 10-Q · filed 2022-11-03 | -773.81K shares derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | 42.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 277.00K shares 10-Q · filed 2022-08-04 | -825.81K shares derived: sum of 3 quarters · filed 2022-08-04 | -762.81K shares derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | 235.00K shares 10-Q · filed 2022-05-11 | -867.81K shares derived: sum of 2 quarters · filed 2022-05-11 | -804.81K shares derived: sum of 3 quarters · filed 2022-05-11 | -621.81K shares derived: sum of 4 quarters · filed 2022-05-11 |
| 2021-12-31 | -1.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | -1.04M shares derived: sum of 2 quarters · filed 2022-03-14 | -856.81K shares derived: sum of 3 quarters · filed 2022-03-14 | 1.19K shares 10-K · filed 2022-03-14 |
| 2021-09-30 | 63.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | 246.00K shares derived: sum of 2 quarters · filed 2021-11-15 | 1.10M shares 10-Q · filed 2021-11-15 | 1.10M shares derived: sum of 4 quarters · filed 2021-11-15 |
| 2021-06-30 | 183.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | 1.04M shares 10-Q · filed 2021-08-10 | 1.04M shares derived: sum of 3 quarters · filed 2021-08-10 | |
| 2021-03-31 | 858.00K shares 10-Q · filed 2021-05-11 | 857.00K shares derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2020-12-31 | -1.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | 828.00K shares 10-K · filed 2021-03-16 | ||
| 2020-09-30 | 829.00K shares 10-Q · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |